Welsis (WLSS) Cash & Current Investments (2022 - 2023)
Welsis (WLSS) recorded quarterly Cash & Current Investments of $1368.0 in Q4 2023, down 86.09% quarter-over-quarter from $9834.0 in Q3 2023, and down 90.43% on a YoY basis from $14292.0 in Q4 2022.
Welsis (WLSS) Cash & Current Investments (2022 - 2023) Analysis & Trends
Welsis' Cash & Current Investments history runs 2 years deep, the most recent figure standing at $1368.0 for Q4 2023.
- In Q4 2023, Cash & Current Investments fell 90.43% year-over-year to $1368.0; the TTM figure through Dec 2023 stood at $1368.0 (down 90.43% YoY), while the FY2023 annual figure was $9834.0, down 47.42% from the prior year.
- Cash & Current Investments was $1368.0 for Q4 2023 at Welsis, down from $9834.0 in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $18703.0 in Q3 2022 to a low of $963.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | 7.31 Bn |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | 888.80 Mn |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | 265.37 Mn |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | 315.87 Mn |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | 748.60 Mn |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | 539.85 Mn |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | 158.93 Mn |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | 419.52 Mn |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | 174.90 Mn |
| 10 | Welsis | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1,368.00 |
| Sep 30, 2023 | 9,834.00 |
| Jun 30, 2023 | 5,202.00 |
| Mar 31, 2023 | 963.00 |
| Dec 31, 2022 | 14,292.00 |
| Sep 30, 2022 | 18,703.00 |
| Jun 30, 2022 | 1,640.00 |